UTHR FY 2025 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3.2B+10.6% YoY

Gross Profit

$2.8B87.9% margin

Operating Income

$1.5B46.9% margin

Net Income

$1.3B41.9% margin

EPS (Diluted)

$27.86

Cash Flow

Operating Cash Flow

$1.6B

Free Cash Flow

$1.0B

Stock-Based Comp.

$148M

Balance Sheet

Total Assets

$7.9B

Total Liabilities

$784M

Stockholders' Equity

$7.1B

Cash & Equivalents

$1.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.2B	$2.9B	+10.6%
Gross Profit	$2.8B	$2.6B	+9.0%
Operating Income	$1.5B	$1.4B	+8.4%
Net Income	$1.3B	$1.2B	+11.7%